Get started
Author

Chiara De‐Colle

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial
2021 · S. Peters, J.-L. Pujol, et al. · Annals of Oncology · 125
PDF
Partial breast irradiation with the 1.5 T MR-Linac: First patient treatment and analysis of electron return and stream effects
2019 · Marcel Nachbar, David Mönnich, et al. · Radiotherapy and Oncology · 80
Optimizing MR-Guided Radiotherapy for Breast Cancer Patients
2020 · Maureen L. Groot Koerkamp, Jeanine E. Vasmel, et al. · Frontiers in Oncology · 55
PDF
Quality of life and fatigue before and after radiotherapy in breast cancer patients
2020 · Franziska Hauth, Chiara De-Colle, et al. · Strahlentherapie und Onkologie · 39
Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness
2015 · Apostolos Menegakis, Chiara De Colle, et al. · Radiotherapy and Oncology · 39
PDF
Once-Weekly Hypofractionated Whole-Breast Radiotherapy After Breast-Conserving Surgery in Older Patients: A Potential Alternative Treatment Schedule to Daily 3-Week Hypofractionation
2015 · Paolo Rovea, Alessandra Fozza, et al. · Clinical Breast Cancer · 37
SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy
2017 · Chiara De-Colle, Apostolos Menegakis, et al. · Radiotherapy and Oncology · 32
Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis
2023 · Elgin Hoffmann, Chiara De-Colle, et al. · Strahlentherapie und Onkologie · 20
PDF
Adaptive radiotherapy for breast cancer
2022 · C. De-Colle, A. Kirby, et al. · Clinical and Translational Radiation Oncology · 20
PDF
SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
2017 · Chiara De-Colle, David Mönnich, et al. · Clinical and Translational Radiation Oncology · 20
PDF
Ex vivo γH2AX radiation sensitivity assay in prostate cancer: Inter-patient and intra-patient heterogeneity
2017 · Chiara De-Colle, Ala Yaromina, et al. · Radiotherapy and Oncology · 19
Analysis of the electron-stream effect in patients treated with partial breast irradiation using the 1.5 T MR-linear accelerator
2021 · C. De-Colle, M. Nachbar, et al. · Clinical and Translational Radiation Oncology · 18
Hyperthermic chest wall re-irradiation in recurrent breast cancer: a prospective observational study
2019 · C. De-Colle, N. Weidner, et al. · Strahlentherapie und Onkologie · 18
Heterotopic ossifications: role of radiotherapy as prophylactic treatment
2018 · Maria Grazia Ruo Redda, Chiara De Colle, et al. · La radiologia medica · 14
Hypofractionation with no boost after breast conservation in early-stage breast cancer patients
2016 · Francesca Arcadipane, Pierfrancesco Franco, et al. · Medical Oncology · 13
PDF
Radiotherapy and hyperthermia for breast cancer patients at high risk of recurrence
2022 · Chiara De-Colle, Anna Beller, et al. · International Journal of Hyperthermia · 11
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
2020 · Maja Guberina, Ali Sak, et al. · The Pharmacogenomics Journal · 10
PDF
Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC – Hypothesis generation on a multicentre cohort of the DKTK-ROG
2022 · Steffen Löck, Annett Linge, et al. · Radiotherapy and Oncology · 7
Validation of a Monte Carlo-based dose calculation engine including the 1.5 T magnetic field for independent dose-check in MRgRT
2025 · Ruggero Ruggieri, Nicola Bianchi, et al. · Physica Medica · 6
The Clinical Feasibility and Safety of 1.5 T MR-Guided Daily Adapted Radiotherapy in 1000 Patients: A Real-World Large Experience of an Early-Adopter Center
2025 · Chiara De-Colle, Michele Rigo, et al. · Cancers · 5
PDF
First clinical application of Comprehensive Motion Management with 1.5T MR-linac on prostate cancer patients treated with radiotherapy: technical aspects and suggested workflow recommendations
2025 · Luca Nicosia, Michele Rigo, et al. · La radiologia medica · 5
Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy
2024 · E. Hoffmann, A. Toepell, et al. · Strahlentherapie und Onkologie · 5
PDF
γH2AX foci assay in glioblastoma: Surgical specimen versus corresponding stem cell culture
2021 · Andreas Riedel, Lukas Klumpp, et al. · Radiotherapy and Oncology · 4
Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy—a case report and literature review
2024 · Elgin Hoffmann, Simon Böke, et al. · Strahlentherapie und Onkologie · 3
PDF
Stereotactic Body Radiotherapy for Spinal Oligometastases With or Without Simultaneous Integrated Boost: Results From a Monocentric Retrospective Analysis
2025 · E. Pastorello, L. Nicosia, et al. · Clinical Oncology · 2
Works count: 57
Citation count: 619
H-index: 14
I10-index: 17
Year
Topic
Type